Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

Patients with cancer who develop stroke are at high risk for future strokes or other clotting events. These patients are routinely treated with medicines that thin their blood, including enoxaparin or aspirin. However, it is unclear which medicine is best and whether these medicines can be adequately studied in a clinical trial. The purpose of this Phase I/II study is to determine if a clinical trial of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 October 2017.

1 Dec 2012 20 Dec 2012 1 Dec 2018 1 Dec 2018 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts

  • Lisa DeAngelis, MD

    212-639-7123

  • Babak Navi, MD

    212-639-7123